Dale Curtis Hogue Jr. - 29 Mar 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Chief Executive Officer, Interim, Director
Signature
/s/ Melinda Lackey, attorney in fact
Issuer symbol
TCRT
Transactions as of
29 Mar 2025
Net transactions value
$0
Form type
4
Filing time
01 Apr 2025, 16:21:00 UTC
Previous filing
23 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +3,000 $0.000000 3,000 29 Mar 2025 Common Stock 3,000 $1.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixth of the shares underlying the option vest in equal monthly installments measured from March 29, 2025, with the first vesting occurring on April 29, 2025 subject to the Reporting Person's continued service through each vesting date.

Remarks:

Chief Executive Officer, Interim